Jennifer Schneiderman, MD, MS

Attending Physician, Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation

Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Stem cell transplantation, reduced intensity conditioning regimens, neuroblastoma, apheresis

Specialties, Programs & Conditions

Specialties:

Hematology & Oncology

Programs & Conditions:

Stem Cell Transplantation Program

Education & Training

Education: Chicago Medical School, 1998

Postgraduate Training: Fellowship in stem cell transplantation, Children's Memorial Hospital, 2006-2007; Fellowship in pediatric hematology/oncology, Children's Memorial Hospital, 2003-2006; Residency in pediatrics, Children's Hospital of Orange County, CA, 1998-2002

Board Certifications: Pediatric Hematology-Oncology, General Pediatrics

Professional Organizations: American Society of Bone Marrow Transplantation; American Society of Hematology

See Northwestern University Faculty Profile >

Research

Northwestern Scholars Profile >

Publications

Most recent publications

The Impact of High-resolution HLA-A, HLA-B, HLA-C, and HLA-DRB1 on Transplant-related Outcomes in Single-unit Umbilical Cord Blood Transplantation in Pediatric Patients J Pediatr Hematol Oncol39 (1): 26-32
Report of the ASFA apheresis registry study on Wilson's disease J Clin Apher31 (1): 11-5
Single Daily Busulfan Dosing for Infants with Nonmalignant Diseases Undergoing Reduced-Intensity Conditioning for Allogeneic Hematopoietic Progenitor Cell Transplantation Biol Blood Marrow Transplant21 (9): 1612-21
The use of fluid boluses to safely perform extracorporeal photopheresis (ECP) in low-weight children: a novel procedure J Clin Apher25 (2): 63-9
Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group J Clin Oncol26 (6): 913-8
Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants J Pediatr Hematol Oncol40 (1): 31-35
Extracorporeal photopheresis in pediatric patients: Practical and technical considerations J Clin Apher32 (6): 543-552
Allogeneic hematopoetic stem cell transplantation in pediatric myelodysplastic syndromes: improved outcomes for de novo disease Pediatr Transplant15 (3): 334-43
Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant Bone Marrow Transplant44 (3): 145-56
Correction of enzyme levels with allogeneic hematopoeitic progenitor cell transplantation in Niemann-Pick type B Pediatr Blood Cancer49 (7): 987-9